Are you comfortable prescribing HRT?
POLL: How do you compare with your colleagues in your comfort level for prescribing hormone replacement therapy for symptoms of menopause.
Vasomotor symptoms and other symptoms related to decreased estrogen levels from menopause are costly to women as well as the health care system. Women who experience them are burdened with hot flashes, sleep disturbances, and a variety of other issues that can diminish their quality of both home and work life, including dyspareunia, anxiety, depression, irritability, and memory impairment. Also, research has shown that untreated vasomotor symptoms are associated with significant increases in healthcare utilization, work loss, and cost burden.
The one treatment that most effectively manages many of these symptoms is hormone therapy, but an analysis has shown that the use of hormone replacement therapy is associated with an increased risk of the two most common forms of ovarian cancer. Also, another analysis has shown that HRT isn't cardioprotective.
Considering these new findings, how comfortable are you in prescribing HRT to women who experience moderate to severe vasomotor symptoms? (Assume there are no contraindications based on patient history.)
Low creatinine-to-cystatin C ratio linked to postmenopausal muscle loss
March 20th 2025A new study finds that postmenopausal women with a reduced creatinine-to-cystatin C ratio experience decreased muscle volume and slower walking speed, highlighting its role as a potential biomarker for muscle health.
Read More
